W STRATEGIES, LLC

Lobbying for ABBVIE INC. · Biopharmaceutical company.

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · $50,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Medicare/Medicaid

Medicare Implementation of the Inflation Reduction Act. Issues around drug pricing.

Health Issues

Education and legislation related to reform of the 340(b) program. Education around data privacy.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.